Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC

HIK

Rang in aandelen #25461
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the... Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.
Aandeelprijs
$22.61
Marktkapitalisatie
$46.82M
Verandering (1 dag)
0.48%
Verandering (1 jaar)
-52.37%
Land
GB
Handel Hikma Pharmaceuticals PLC (HIK)

Categorie

Healthcare
Prijs HIK met de marktkapitalisatie van B
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC
HIK
$22.61
Marktkapitalisatie van Hikma Pharmaceuticals PLC(HIK)
Marktkapitalisatie: $46.82M
Vanaf October 2026 heeft Hikma Pharmaceuticals PLC een marktkapitalisatie van $46.82M. Dit maakt Hikma Pharmaceuticals PLC volgens onze gegevens het 25461st meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Hikma Pharmaceuticals PLC van 2011 tot 2026
HIK vergeleken met de top 5 populairste stocks
Prijs voor HIK Aandeel B Marktkapitalisatie van B uitslagen
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC
$50,755.11 $4.57B
$5.252T +114,860.62%
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC
$48,328.90 $4.57B
$5.001T +109,365.24%
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC
$40,355.48 $4.57B
$4.176T +91,305.40%
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC
$38,344.64 $4.57B
$3.968T +86,750.82%
Hikma Pharmaceuticals PLC Hikma Pharmaceuticals PLC
$27,415.81 $4.57B
$2.837T +61,996.97%